Digital & Future Technologies Ltd (D&F) is a UK technology and innovation company specialising in the development, protection and commercialisation of advanced technologies across digital health, artificial intelligence, medical devices, aerospace and connected systems. The company focuses on translating technologies and engineering approaches from high-performance and highly regulated environments into practical solutions addressing healthcare and societal challenges.
Within healthcare, D&F is the technology and intellectual property company behind YourHeartCheck.com. D&F holds the core intellectual property and operates YourHeartCheck.com as the commercial platform through which its cardiovascular technologies and diagnostic services are brought to market.
YourHeartCheck.com has been developed to make advanced cardiovascular diagnostics more accessible outside traditional hospital environments. The platform provides extended ambulatory ECG monitoring, combining clinical-grade ECG recording with professional analysis, digital reporting and patient-friendly communication of results. The wider strategy is to develop an integrated cardiovascular assessment platform suitable for direct-to-patient, pharmacy, community healthcare and clinical pathways.
A major area of D&F's current R&D is its patented ECG-to-Blood Pressure technology. Using artificial intelligence and machine-learning analysis of ECG time-series data, the technology is being developed to derive blood-pressure-related information from ECG recordings without relying upon repeated conventional cuff measurements.
The technology has been developed using large-scale datasets, including data from approximately 41,000 UK Biobank participants. By combining ECG with blood-pressure-related information, heart rate, heart-rate variability, activity, accelerometry and circadian data, D&F aims to provide a richer longitudinal picture of cardiovascular behaviour during normal daily life.
The longer-term objective extends beyond simply developing another method of measuring blood pressure. D&F is building a cardiovascular analytics capability in which ECG can become a platform from which multiple physiological insights are derived. Potential applications include preventative healthcare, hypertension, cardiovascular risk assessment, remote patient monitoring, hospital-at-home programmes and community diagnostics.
D&F has an established track record of technology and intellectual property development, with a portfolio of patented innovations across multiple sectors. Its engineering philosophy is strongly influenced by experience in Formula One and aerospace, where complex real-time data must be transformed rapidly into actionable information.
Through YourHeartCheck.com, D&F can connect R&D and clinical innovation directly with real-world commercial deployment. This provides an important environment for evaluating not only technical and clinical performance, but also patient engagement, usability, operational delivery and new healthcare business models.
Digital & Future Technologies is particularly interested in European collaborations involving cardiovascular diagnostics, AI and machine learning, hypertension, digital biomarkers, remote patient monitoring, preventative medicine and community healthcare. The company is seeking clinical, academic, technology and commercial partners for collaborative R&D, clinical validation, regulatory development and European deployment.
Our ambition is to move cardiovascular monitoring beyond isolated measurements towards intelligent, longitudinal assessment of cardiovascular behaviour in everyday life — providing clinicians and individuals with better information, earlier insight and more accessible cardiovascular healthcare.